CI Investments Inc
BPMC

CI Investments Inc’s Blueprint Medicines BPMC Stock Holding History

CI Investments Inc’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-971
Closed -$124K – 1290
2025
Q2 		$124K Sell
971
-50
-5% -$5.19K ﹤0.01% 856
2025
Q1 		$90K Sell
1,021
-620
-38% -$60.5K ﹤0.01% 946
2024
Q4 		$143K Buy
1,641
+169
+11% +$15.5K ﹤0.01% 834
2024
Q3 		$136K Buy
+1,472
New +$146K ﹤0.01% 763
2023
Q1 		– Sell
-3
Closed – – 1168
2022
Q4 		$0 Hold
3
– – ﹤0.01% 1207
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1225
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1250
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1309
2021
Q4 		$0 Hold
3
– – ﹤0.01% 1291
2021
Q3 		$0 Buy
+3
New +$279 ﹤0.01% 1267

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CI Investments Inc's BPMC Position: Q3 2025 in Review

CI Investments Inc sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 971 shares — an estimated $124K sold.

CI Investments Inc first reported a position in BPMC in Q3 2021 and held it in 10 quarters. The position peaked at $143K in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • CI Investments Inc reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • CI Investments Inc sold 971 Blueprint Medicines shares in Q3 2025, an estimated $124K.
  • CI Investments Inc first reported a position in Blueprint Medicines in Q3 2021 and held it in 10 quarters.
  • CI Investments Inc's Blueprint Medicines position peaked at $143K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on CI Investments Inc's 13F filing for Q3 2025, filed 12 Nov 2025.